Degradation of bradykinin, a cardioprotective substance, during a single passage through isolated rat-heart

M. Ahmad, I. J. Zeitlin, J. Parratt, A. R. Pitt

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Angiotensin converting enzyme (ACE) inhibitors have cardioprotective effects in different species including human. This cardioprotective effect is mainly due to the inhibition of bradykinin (BK) degradation rather than inhibition of the conversion of angiotensin I to angiotensin II. Bradykinin, a nonapeptide, has been considered to be the potential target for various enzymes including ACE, neutral endopeptidase 24.11, carboxypeptidase M, carboxypeptidase N, proline aminopeptidase, endopeptidase 24.15, and meprin. In the present study, the coronary vascular beds of Sprague Dawley rat isolated hearts were perfused (single passage) with Krebs solution alone or with different concentrations of BK i.e. 2.75×10-10, 10-7, 10 -6 and 10-5 M solution. Percent degradation of BK was determined by radioimmunoassay. The degradation products of BK after passing through the isolated rat-hearts were determined using RP-HPLC and mass spectroscopy. All the four doses of BK significantly decreased the perfusion pressure during their passage through the hearts. The percentage degradation of all four doses was decreased as the concentration of drug was increased, implying saturation of a fixed number of active sites involved in BK degradation. Bradykinin during a single passage through the hearts degraded to give [1-7]-BK as the major metabolite, and [1-8]-BK as a minor metabolite, detected on HPLC. Mass spectroscopy not only confirmed the presence of these two metabolites but also detected traces of [1-5]-BK and arginine. These findings showed that primarily ACE is the major cardiac enzyme involved in the degradation of bradykinin during a single passage through the coronary vascular of bed the healthy rat heart, while carboxypeptidase M may have a minor role.

Original languageEnglish
Pages (from-to)241-248
Number of pages8
JournalArchives of Pharmacal Research
Volume29
Issue number3
DOIs
Publication statusPublished - Mar 31 2006

Fingerprint

Bradykinin
Rats
Degradation
Metabolites
Peptidyl-Dipeptidase A
bradykinin (1-5)
prolyl oligopeptidase
thimet oligopeptidase
Blood Vessels
Mass Spectrometry
Lysine Carboxypeptidase
Tiopronin
High Pressure Liquid Chromatography
Spectroscopy
Neprilysin
Angiotensin I
Enzymes
Angiotensin-Converting Enzyme Inhibitors
Angiotensin II
Radioimmunoassay

Keywords

  • Angiotensin converting enzyme
  • Bradykinin
  • Carboxypeptidase M
  • Rat heart

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

Degradation of bradykinin, a cardioprotective substance, during a single passage through isolated rat-heart. / Ahmad, M.; Zeitlin, I. J.; Parratt, J.; Pitt, A. R.

In: Archives of Pharmacal Research, Vol. 29, No. 3, 31.03.2006, p. 241-248.

Research output: Contribution to journalArticle

@article{24851b8107284906a1f362845a7aa8bc,
title = "Degradation of bradykinin, a cardioprotective substance, during a single passage through isolated rat-heart",
abstract = "Angiotensin converting enzyme (ACE) inhibitors have cardioprotective effects in different species including human. This cardioprotective effect is mainly due to the inhibition of bradykinin (BK) degradation rather than inhibition of the conversion of angiotensin I to angiotensin II. Bradykinin, a nonapeptide, has been considered to be the potential target for various enzymes including ACE, neutral endopeptidase 24.11, carboxypeptidase M, carboxypeptidase N, proline aminopeptidase, endopeptidase 24.15, and meprin. In the present study, the coronary vascular beds of Sprague Dawley rat isolated hearts were perfused (single passage) with Krebs solution alone or with different concentrations of BK i.e. 2.75×10-10, 10-7, 10 -6 and 10-5 M solution. Percent degradation of BK was determined by radioimmunoassay. The degradation products of BK after passing through the isolated rat-hearts were determined using RP-HPLC and mass spectroscopy. All the four doses of BK significantly decreased the perfusion pressure during their passage through the hearts. The percentage degradation of all four doses was decreased as the concentration of drug was increased, implying saturation of a fixed number of active sites involved in BK degradation. Bradykinin during a single passage through the hearts degraded to give [1-7]-BK as the major metabolite, and [1-8]-BK as a minor metabolite, detected on HPLC. Mass spectroscopy not only confirmed the presence of these two metabolites but also detected traces of [1-5]-BK and arginine. These findings showed that primarily ACE is the major cardiac enzyme involved in the degradation of bradykinin during a single passage through the coronary vascular of bed the healthy rat heart, while carboxypeptidase M may have a minor role.",
keywords = "Angiotensin converting enzyme, Bradykinin, Carboxypeptidase M, Rat heart",
author = "M. Ahmad and Zeitlin, {I. J.} and J. Parratt and Pitt, {A. R.}",
year = "2006",
month = "3",
day = "31",
doi = "10.1007/BF02969400",
language = "English",
volume = "29",
pages = "241--248",
journal = "Archives of Pharmacal Research",
issn = "0253-6269",
publisher = "Pharmaceutical Society of Korea",
number = "3",

}

TY - JOUR

T1 - Degradation of bradykinin, a cardioprotective substance, during a single passage through isolated rat-heart

AU - Ahmad, M.

AU - Zeitlin, I. J.

AU - Parratt, J.

AU - Pitt, A. R.

PY - 2006/3/31

Y1 - 2006/3/31

N2 - Angiotensin converting enzyme (ACE) inhibitors have cardioprotective effects in different species including human. This cardioprotective effect is mainly due to the inhibition of bradykinin (BK) degradation rather than inhibition of the conversion of angiotensin I to angiotensin II. Bradykinin, a nonapeptide, has been considered to be the potential target for various enzymes including ACE, neutral endopeptidase 24.11, carboxypeptidase M, carboxypeptidase N, proline aminopeptidase, endopeptidase 24.15, and meprin. In the present study, the coronary vascular beds of Sprague Dawley rat isolated hearts were perfused (single passage) with Krebs solution alone or with different concentrations of BK i.e. 2.75×10-10, 10-7, 10 -6 and 10-5 M solution. Percent degradation of BK was determined by radioimmunoassay. The degradation products of BK after passing through the isolated rat-hearts were determined using RP-HPLC and mass spectroscopy. All the four doses of BK significantly decreased the perfusion pressure during their passage through the hearts. The percentage degradation of all four doses was decreased as the concentration of drug was increased, implying saturation of a fixed number of active sites involved in BK degradation. Bradykinin during a single passage through the hearts degraded to give [1-7]-BK as the major metabolite, and [1-8]-BK as a minor metabolite, detected on HPLC. Mass spectroscopy not only confirmed the presence of these two metabolites but also detected traces of [1-5]-BK and arginine. These findings showed that primarily ACE is the major cardiac enzyme involved in the degradation of bradykinin during a single passage through the coronary vascular of bed the healthy rat heart, while carboxypeptidase M may have a minor role.

AB - Angiotensin converting enzyme (ACE) inhibitors have cardioprotective effects in different species including human. This cardioprotective effect is mainly due to the inhibition of bradykinin (BK) degradation rather than inhibition of the conversion of angiotensin I to angiotensin II. Bradykinin, a nonapeptide, has been considered to be the potential target for various enzymes including ACE, neutral endopeptidase 24.11, carboxypeptidase M, carboxypeptidase N, proline aminopeptidase, endopeptidase 24.15, and meprin. In the present study, the coronary vascular beds of Sprague Dawley rat isolated hearts were perfused (single passage) with Krebs solution alone or with different concentrations of BK i.e. 2.75×10-10, 10-7, 10 -6 and 10-5 M solution. Percent degradation of BK was determined by radioimmunoassay. The degradation products of BK after passing through the isolated rat-hearts were determined using RP-HPLC and mass spectroscopy. All the four doses of BK significantly decreased the perfusion pressure during their passage through the hearts. The percentage degradation of all four doses was decreased as the concentration of drug was increased, implying saturation of a fixed number of active sites involved in BK degradation. Bradykinin during a single passage through the hearts degraded to give [1-7]-BK as the major metabolite, and [1-8]-BK as a minor metabolite, detected on HPLC. Mass spectroscopy not only confirmed the presence of these two metabolites but also detected traces of [1-5]-BK and arginine. These findings showed that primarily ACE is the major cardiac enzyme involved in the degradation of bradykinin during a single passage through the coronary vascular of bed the healthy rat heart, while carboxypeptidase M may have a minor role.

KW - Angiotensin converting enzyme

KW - Bradykinin

KW - Carboxypeptidase M

KW - Rat heart

UR - http://www.scopus.com/inward/record.url?scp=33646492196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646492196&partnerID=8YFLogxK

U2 - 10.1007/BF02969400

DO - 10.1007/BF02969400

M3 - Article

C2 - 16596998

AN - SCOPUS:33646492196

VL - 29

SP - 241

EP - 248

JO - Archives of Pharmacal Research

JF - Archives of Pharmacal Research

SN - 0253-6269

IS - 3

ER -